Endoscopy Devices Market Size to Hit USD 112.30 Billion by 2033

Endoscopy Devices Market Size, Share, Growth, Trends, Segmental Analysis, By Product (Endoscopes — Flexible Endoscopes, Rigid Endoscopes, Capsule Endoscopes, Robot-Assisted Endoscopes; Endoscopy Visualization Systems — HD Imaging Systems, 4K Imaging Systems, 3D Imaging Systems; Endoscopy Operative Devices — Biopsy Forceps, Graspers, Scissors, Clip Appliers; Endoscopy Fluid Management Systems; Endoscopy Irrigation Pumps), By Application (Gastrointestinal Endoscopy, Laparoscopy, Arthroscopy, Bronchoscopy, Urology, Gynecology, Otolaryngology), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Imaging Centers), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Market Forecast, 2026 – 2033

  • Published: Apr, 2026
  • Report ID: 447
  • Pages: 160+
  • Format: PDF / Excel.

This report contains the Latest Market Figures, Statistics, and Data.

Get a Sample
logo

Endoscopy Devices Market Size to Hit USD 112.30 Billion by 2033

(An Updated Version is Available)

1. Preface

  • 1.1 Report Description and Scope

  • 1.2 Research Objectives

  • 1.3 Key Assumptions and Limitations

  • 1.4 Target Audience

2. Executive Summary

  • 2.1 Market Overview and Snapshot

  • 2.2 Key Market Findings and Highlights

  • 2.3 Market Size Estimation and Forecast Summary

  • 2.4 Key Trends at a Glance

  • 2.5 Recommendations for Market Participants

3. Research Methodology

  • 3.1 Research Design and Approach

  • 3.2 Primary Research (Clinician Interviews, Hospital Procurement Surveys, ASC Administrator Interactions, KOL Consultations)

  • 3.3 Secondary Research (Annual Reports, FDA 510(k)/EU MDR Databases, NIH, ACS, WHO Publications, ASGE Data, Industry Journals)

  • 3.4 Top-Down and Bottom-Up Estimation Approach

  • 3.5 Data Triangulation and Validation

  • 3.6 Market Forecast Assumptions and Key Parameters

4. Market Overview

  • 4.1 Introduction to Endoscopy Devices and Their Role in Minimally Invasive Medicine

  • 4.2 Historical Market Background and Evolution (Rigid Optics → HD Flexible Systems → AI-Integrated Platforms)

  • 4.3 Market Scope and Definition

  • 4.4 Parent Market and Adjacent Market Analysis (Minimally Invasive Devices, Surgical Visualization Systems, Endoscope Reprocessing Market)

  • 4.5 Regulatory Overview (FDA 510(k) Class II, EU MDR, PMDA, NMPA, ISO 11135, ISO 13485, GMP Framework)

  • 4.6 Reusable vs. Disposable Endoscopy Devices: Infection Control, Cost-Efficiency, and Clinical Tradeoff Analysis

  • 4.7 Technology and Product Innovation Timeline

5. Market Dynamics

  • 5.1 Market Drivers

    • 5.1.1 Rising Global Preference for Minimally Invasive Surgical and Diagnostic Procedures

    • 5.1.2 Increasing Prevalence of Gastrointestinal Disorders, Colorectal Cancer, IBD, and Chronic Respiratory Diseases

    • 5.1.3 Rising Investments, Funds, and Government Grants for Endoscopy Cancer Screening Programs

    • 5.1.4 Technological Advancements — AI-Assisted Imaging (CADe/CADx), 4K/3D Visualization, and Robot-Assisted Endoscopy

    • 5.1.5 Growing Geriatric Population Susceptible to Chronic Conditions Requiring Endoscopic Interventions

    • 5.1.6 Expanding Ambulatory Surgical Centers and Outpatient Diagnostic Endoscopy Units

    • 5.1.7 Surge in Demand for Single-Use Endoscopy Devices to Prevent Cross-Contamination and HAIs

  • 5.2 Market Restraints

    • 5.2.1 High Overhead, Capital, and Reprocessing Costs for Reusable Endoscopy Devices in Smaller Facilities

    • 5.2.2 Risk of Viral and Bacterial Infections During Endoscopic Procedures and Reprocessing Failures

    • 5.2.3 Product Recalls and Regulatory Scrutiny (e.g., Duodenoscope Contamination FDA Warnings) Affecting Market Confidence

    • 5.2.4 Shortage of Trained Physicians and Skilled Endoscopists in Developing and Rural Markets

    • 5.2.5 Lack of Proper Sterilization and Reprocessing Infrastructure in Emerging Healthcare Settings

  • 5.3 Market Opportunities

    • 5.3.1 Rapidly Developing Healthcare Sector in Emerging Economies (India, China, Brazil, Southeast Asia)

    • 5.3.2 Increasing Adoption of Single-Use Flexible Endoscopes for Infection Control and Workflow Efficiency

    • 5.3.3 AI-Powered Computer-Aided Detection/Diagnosis (CADe/CADx) Platforms for Polyp, Lesion, and Cancer Identification

    • 5.3.4 Expansion of Capsule and Wireless Endoscopy for Non-Invasive Small Bowel and Colorectal Diagnostics

    • 5.3.5 Growth of Robot-Assisted Endoscopy Platforms for Complex Anatomical Navigation and Precision Surgery

    • 5.3.6 Integration of Cloud-Based PACS, Digital Imaging Archives, and AI Workflow Platforms Across Multi-Site Systems

    • 5.3.7 Strategic Collaborations Between OEMs, AI Firms, and Hospital Systems for Integrated Visualization Ecosystems

  • 5.4 Market Challenges

    • 5.4.1 Product Recalls and Post-Market Surveillance Requirements Under FDA and EU MDR Frameworks

    • 5.4.2 Physician Training Gaps in Advanced Endoscopic Techniques and Digital Platform Adoption

    • 5.4.3 Regulatory Complexity Across Multi-Jurisdictional Markets for Combination AI-Endoscopy Products

    • 5.4.4 Balancing Device Durability, 4K/HD Imaging Performance, and Total Cost of Ownership

6. Market Trends and Key Insights

  • 6.1 Accelerating Transition from Reusable to Single-Use Endoscopy Devices for Infection Prevention

  • 6.2 Widespread Adoption of AI-Powered Computer-Aided Detection (CADe) Systems — Olympus CADDIE, Medtronic GI Genius, FUJIFILM CAD EYE

  • 6.3 Expansion of 4K Ultra-HD, 3D, and Fluorescence/NBI Imaging Systems Across Gastroenterology, Pulmonology, and Surgery

  • 6.4 Robot-Assisted Endoscopy Gaining Traction for Complex GI, Bronchoscopy, and Interventional Procedures

  • 6.5 Surge in Capsule and Wireless Endoscopy as Non-Invasive Alternatives for GI Tract Visualization

  • 6.6 Procedure Migration to ASCs and Outpatient Facilities — Prioritizing Portability, Lower Total Cost, and Uptime

  • 6.7 Integration of Fluorescence Imaging and SPY Overlay Technology for Intraoperative Guidance

  • 6.8 ESG Focus — Single-Use Endoscope Take-Back Programs and Eco-Responsible Device Design

7. Impact Assessment

  • 7.1 Impact of COVID-19 on the Endoscopy Devices Market

    • 7.1.1 Pre-COVID Market Scenario

    • 7.1.2 Pandemic Impact: >50% Reduction in Endoscopic Procedure Volumes in 85% of Global Countries (2020)

    • 7.1.3 Post-COVID Recovery: Procedure Backlog, Expanded Screening Mandates, and Digital Endoscopy Adoption

  • 7.2 Macroeconomic Indicators and Their Influence on Market Growth

  • 7.3 Impact of FDA QSR Reforms, EU MDR Transition, and WHO Cancer Screening Initiative on Device Procurement

  • 7.4 Geopolitical Factors, Trade Tariffs, and Medical Device Import/Export Dynamics

8. Strategic Framework Analysis

  • 8.1 Value Chain Analysis

    • 8.1.1 Raw Material and Optical Component Suppliers (CMOS/CCD Sensors, Optical Fibers, Polymers, Silicone)

    • 8.1.2 Endoscope and Visualization System Manufacturers and OEMs

    • 8.1.3 Operative Device and Accessory Manufacturers

    • 8.1.4 Contract Manufacturers and Assemblers

    • 8.1.5 Reprocessing and Sterilization Service Providers

    • 8.1.6 Distributors and Regional Channel Partners

    • 8.1.7 End Users — Hospitals, ASCs, Specialty Clinics, Outpatient Diagnostic Centers

  • 8.2 Supply Chain Analysis and Risk Assessment

  • 8.3 Porter's Five Forces Analysis

    • 8.3.1 Threat of New Entrants

    • 8.3.2 Bargaining Power of Buyers

    • 8.3.3 Bargaining Power of Suppliers

    • 8.3.4 Threat of Substitute Technologies (Capsule Endoscopy, CT Colonography, Radiology Imaging)

    • 8.3.5 Competitive Rivalry Among Existing Players

  • 8.4 SWOT Analysis of the Overall Market

  • 8.5 Pricing Analysis and Trends by Product Type, Usability, and Region

  • 8.6 Technology Landscape and Innovation Matrix

    • 8.6.1 AI-Integrated Computer-Aided Endoscopy (CADe/CADx) Platforms

    • 8.6.2 4K Ultra-HD, 3D, and Fluorescence/NBI Imaging Systems

    • 8.6.3 Robot-Assisted Endoscopy Navigation Platforms

    • 8.6.4 Capsule and Wireless Endoscopy Technology

    • 8.6.5 Single-Use / Hybrid Endoscope System Platforms

    • 8.6.6 Cloud-Based PACS and Digital Endoscopy Archiving Integration

  • 8.7 IP and Patent Landscape

  • 8.8 Trade Analysis (Import & Export Trends for Endoscopy Devices)

  • 8.9 Regulatory and Standards Landscape by Region (FDA 510(k)/GMP, EU MDR, PMDA, CDSCO, NMPA, ISO 11135/13485)

  • 8.10 Drivers Impact Analysis on CAGR

9. Global Endoscopy Devices Market — By Product

  • 9.1 Overview and Market Size, 2026–2033

  • 9.2 Endoscopes

    • 9.2.1 Reusable Endoscopes

      • 9.2.1.1 Rigid Endoscopes

        • Laparoscopes

        • Arthroscopes

        • Ureteroscopes

        • Cystoscopes

        • Gynecology Endoscopes (Hysteroscopes, Colposcopes)

        • Neuroendoscopes

        • Bronchoscopes

        • Laryngoscopes

        • ENT Endoscopes (Sinuscopes, Otoscopes, Rhinoscopes, Nasopharyngoscopes, Pharyngoscopes)

      • 9.2.1.2 Flexible Endoscopes

        • Gastrointestinal Endoscopes (Gastroscope, Colonoscope, Enteroscope, Duodenoscope, Sigmoidoscope)

        • Bronchoscopes

        • Flexible Ureteroscopes

        • Flexible Laryngoscopes

      • 9.2.1.3 Capsule Endoscopes

      • 9.2.1.4 Robot-Assisted Endoscopes

    • 9.2.2 Disposable / Single-Use Endoscopes

      • 9.2.2.1 Disposable Gastrointestinal Endoscopes (Gastroscope, Colonoscope, Enteroscope, Duodenoscope, Sigmoidoscope)

      • 9.2.2.2 Disposable Urological Endoscopes (Ureteroscopes, Cystoscopes)

      • 9.2.2.3 Disposable Bronchoscopes

      • 9.2.2.4 Disposable Laryngoscopes and ENT Endoscopes

      • 9.2.2.5 Disposable Gynecology Endoscopes

      • 9.2.2.6 Disposable Laparoscopes and Arthroscopes

      • 9.2.2.7 Disposable Neuroendoscopes

    • 9.2.3 Endoscopes — Market Size, Share, and Forecast (41.1% Dominant Share)

    • 9.2.4 Fastest Growing Sub-Segment: Disposable Endoscopes — Infection Control Mandates and ASC Adoption

  • 9.3 Endoscopy Visualization Systems

    • 9.3.1 Reusable Endoscopy Visualization Systems

      • 9.3.1.1 Standard Definition (SD) Visualization Systems

        • 2D Systems

        • 3D Systems

      • 9.3.1.2 High Definition (HD) Visualization Systems

        • 2D Systems

        • 3D Systems

      • 9.3.1.3 4K Ultra-HD Visualization Systems

      • 9.3.1.4 AI-Integrated Visualization Systems (CADe/CADx Platforms — Olympus CADDIE, Medtronic GI Genius, FUJIFILM CAD EYE)

    • 9.3.2 Market Size, Share, and Forecast

    • 9.3.3 Fastest Growing Product (12.53% CAGR): Continuous Advancement in HD/4K Imaging and AI-Assisted Workflows

  • 9.4 Endoscopy Visualization Components

    • 9.4.1 Reusable Endoscopy Visualization Components

      • 9.4.1.1 Camera Heads

      • 9.4.1.2 Insufflators

      • 9.4.1.3 Light Sources

      • 9.4.1.4 High-Definition Monitors

      • 9.4.1.5 Suction Pumps

      • 9.4.1.6 Video Processors

    • 9.4.2 Disposable Endoscopy Visualization Components

      • 9.4.2.1 Camera Heads

      • 9.4.2.2 Insufflators

      • 9.4.2.3 Light Sources

      • 9.4.2.4 Suction Pumps

    • 9.4.3 Market Size, Share, and Forecast

  • 9.5 Operative Devices (Endoscopy Accessories)

    • 9.5.1 Reusable Operative Devices

      • 9.5.1.1 Energy Systems

      • 9.5.1.2 Access Devices (Trocars, Cannulas)

      • 9.5.1.3 Suction and Irrigation Systems

      • 9.5.1.4 Hand Instruments (Forceps, Graspers, Scissors)

      • 9.5.1.5 Wound Retractors

      • 9.5.1.6 Snares and Biopsy Forceps

    • 9.5.2 Disposable Operative Devices

      • 9.5.2.1 Energy Systems

      • 9.5.2.2 Access Devices

      • 9.5.2.3 Suction and Irrigation Systems

      • 9.5.2.4 Hand Instruments

      • 9.5.2.5 Wound Retractors

      • 9.5.2.6 Snares and Biopsy Forceps

    • 9.5.3 Market Size, Share, and Forecast

  • 9.6 Endoscopic Ultrasound (EUS) Systems

    • 9.6.1 Market Size, Share, and Forecast

    • 9.6.2 Key Applications: Pancreatic Cancer Staging, GI Submucosal Lesion Assessment

  • 9.7 Endoscope Reprocessing Devices

    • 9.7.1 Automated Endoscope Reprocessors (AERs)

    • 9.7.2 Endoscope Drying Cabinets and Storage Systems

    • 9.7.3 Market Size, Share, and Forecast (81.67% Share in Hygiene Segment)

10. Global Endoscopy Devices Market — By Usability

  • 10.1 Overview and Market Size, 2026–2033

  • 10.2 Reprocessing / Reusable Devices

    • 10.2.1 Market Size, Share, and Forecast (81.67% Dominant Share)

    • 10.2.2 Key Drivers: Established Clinical Protocols, Superior Imaging Performance, and Hospital Infrastructure

  • 10.3 Single-Use / Disposable Devices

    • 10.3.1 Market Size, Share, and Forecast

    • 10.3.2 Fastest Growing Usability Segment (12.47% CAGR): Infection Control Mandates, FDA Guidance on Duodenoscopes, ASC Adoption

11. Global Endoscopy Devices Market — By Application

  • 11.1 Overview and Market Size, 2026–2033

  • 11.2 Gastrointestinal (GI) Endoscopy

    • 11.2.1 Upper GI Endoscopy (Gastroscopy, Esophagoscopy, EGD)

    • 11.2.2 Lower GI Endoscopy (Colonoscopy, Sigmoidoscopy)

    • 11.2.3 ERCP and Endoscopic Retrograde Cholangiopancreatography

    • 11.2.4 Enteroscopy and Small Bowel Endoscopy

    • 11.2.5 Market Size, Share, and Forecast (53.5% Dominant Share: ~23.5 Million GI Endoscopies Annually in the U.S.)

  • 11.3 Laparoscopy

    • 11.3.1 Diagnostic and Operative Laparoscopy

    • 11.3.2 Bariatric and Metabolic Laparoscopic Surgery

    • 11.3.3 Market Size, Share, and Forecast

  • 11.4 Arthroscopy

    • 11.4.1 Knee, Shoulder, Hip, Ankle, and Elbow Arthroscopy

    • 11.4.2 Spine Endoscopy

    • 11.4.3 Market Size, Share, and Forecast

  • 11.5 Bronchoscopy and Pulmonology Endoscopy

    • 11.5.1 Diagnostic Bronchoscopy (BAL, Biopsy, Lung Cancer Screening)

    • 11.5.2 Interventional Bronchoscopy (EBUS, Laser, Stent Placement)

    • 11.5.3 Market Size, Share, and Forecast

  • 11.6 Urology Endoscopy (Cystoscopy and Ureteroscopy)

    • 11.6.1 Cystoscopy and Urethroscopy

    • 11.6.2 Ureteroscopy and Nephrolithiasis Management

    • 11.6.3 Nephroscopy

    • 11.6.4 Market Size, Share, and Forecast

  • 11.7 ENT Endoscopy

    • 11.7.1 Rhinolaryngoscopy and Nasal Endoscopy

    • 11.7.2 Otoscopy and Middle Ear Endoscopy

    • 11.7.3 Sinus Endoscopy (FESS)

    • 11.7.4 Market Size, Share, and Forecast

  • 11.8 Obstetrics and Gynecology Endoscopy

    • 11.8.1 Hysteroscopy

    • 11.8.2 Gynecological Laparoscopy

    • 11.8.3 Market Size, Share, and Forecast

  • 11.9 Neuroendoscopy

    • 11.9.1 Ventriculoscopy and Endoscopic Pituitary Surgery

    • 11.9.2 Market Size, Share, and Forecast

  • 11.10 Mediastinoscopy

    • 11.10.1 Market Size, Share, and Forecast

  • 11.11 Other Applications (Thoracoscopy, Dental, Cardiac Endoscopy)

12. Global Endoscopy Devices Market — By End User

  • 12.1 Overview and Market Size, 2026–2033

  • 12.2 Hospitals

    • 12.2.1 Market Size, Share, and Forecast (61.5% Share: Largest End User)

    • 12.2.2 Key Drivers: Advanced Infrastructure, High Procedural Volume, Specialized Endoscopy Suites, Multidisciplinary Teams

  • 12.3 Outpatient Facilities / Ambulatory Surgical Centers (ASCs)

    • 12.3.1 Market Size, Share, and Forecast (53.6% in Outpatient Category)

    • 12.3.2 Key Drivers: Cost-Effectiveness, Same-Day Procedures, Disposable Scope Preference, Faster Turnover

  • 12.4 Clinics and Specialty Centers

    • 12.4.1 Gastroenterology Clinics

    • 12.4.2 Urology Clinics

    • 12.4.3 Orthopedic and Sports Medicine Clinics

    • 12.4.4 ENT and Pulmonology Clinics

    • 12.4.5 Market Size, Share, and Forecast

  • 12.5 Other End Users (Diagnostic Laboratories, Mobile Endoscopy Units, Academic Research Institutions)

    • 12.5.1 Market Size, Share, and Forecast

13. Global Endoscopy Devices Market — By Region

  • 13.1 Market Overview by Geography

  • 13.2 North America

    • 13.2.1 Market Size and Forecast (39.8% Dominant Share)

    • 13.2.2 United States (Largest Country Market)

    • 13.2.3 Canada (Fastest Growing in North America)

    • 13.2.4 Mexico

    • 13.2.5 Key Drivers, Trends, and Market Dynamics

  • 13.3 Europe

    • 13.3.1 Market Size and Forecast

    • 13.3.2 Germany

    • 13.3.3 United Kingdom

    • 13.3.4 France

    • 13.3.5 Italy

    • 13.3.6 Spain

    • 13.3.7 Denmark

    • 13.3.8 Norway

    • 13.3.9 Sweden

    • 13.3.10 Rest of Europe

    • 13.3.11 Key Drivers, Trends, and Market Dynamics

  • 13.4 Asia Pacific

    • 13.4.1 Market Size and Forecast (Fastest Growing Region)

    • 13.4.2 China (Largest APAC Market)

    • 13.4.3 India

    • 13.4.4 Japan

    • 13.4.5 South Korea

    • 13.4.6 Australia

    • 13.4.7 Thailand

    • 13.4.8 Rest of Asia Pacific

    • 13.4.9 Key Drivers, Trends, and Market Dynamics

  • 13.5 Latin America

    • 13.5.1 Market Size and Forecast

    • 13.5.2 Brazil

    • 13.5.3 Mexico

    • 13.5.4 Argentina

    • 13.5.5 Rest of Latin America

    • 13.5.6 Key Drivers, Trends, and Market Dynamics

  • 13.6 Middle East & Africa

    • 13.6.1 Market Size and Forecast

    • 13.6.2 Saudi Arabia

    • 13.6.3 United Arab Emirates

    • 13.6.4 South Africa

    • 13.6.5 Kuwait

    • 13.6.6 Rest of Middle East & Africa

    • 13.6.7 Key Drivers, Trends, and Market Dynamics

14. Competitive Landscape

  • 14.1 Market Structure and Competitiveness Overview (Moderately Concentrated — Olympus, KARL STORZ, FUJIFILM, Boston Scientific as Leaders)

  • 14.2 Market Share Analysis of Key Players

  • 14.3 Competitive Positioning Matrix

  • 14.4 Key Strategies Adopted by Market Leaders

    • 14.4.1 AI-Integrated Imaging Platform Development (CADe/CADx) and FDA 510(k) Clearances

    • 14.4.2 Single-Use Endoscopy Portfolio Expansion and Infection Control Differentiation (Ambu, Boston Scientific EXALT)

    • 14.4.3 Strategic Acquisitions and Collaborations (Olympus-Odin Vision, Olympus-Taewoong Medical, Boston Scientific-Apollo Endosurgery)

    • 14.4.4 Geographic Expansion — New Manufacturing and R&D Centers in China, India, and Emerging Markets

    • 14.4.5 Outcome-Based Value Selling and Evidence-Driven Procurement Models for Hospital and ASC Partners

  • 14.5 Recent Developments and Industry News (2024–2026)

  • 14.6 Technology and Product Pipeline Analysis

15. Company Profiles
(The final report includes a complete list of companies)

  • 15.1 Olympus Corporation

    • 15.1.1 Company Overview

    • 15.1.2 Financial Performance

    • 15.1.3 Product Portfolio

    • 15.1.4 Strategic Initiatives

    • 15.1.5 SWOT Analysis

  • 15.2 KARL STORZ SE & Co. KG

  • 15.3 FUJIFILM Holdings Corporation

  • 15.4 PENTAX Medical (HOYA Corporation)

  • 15.5 Boston Scientific Corporation

  • 15.6 Medtronic plc

  • 15.7 Stryker Corporation

  • 15.8 Ambu A/S

  • 15.9 STERIS plc

  • 15.10 Richard Wolf GmbH

  • 15.11 Arthrex, Inc.

  • 15.12 Ethicon (Johnson & Johnson MedTech)

  • 15.13 Smith & Nephew plc

  • 15.14 Cook Medical LLC

  • 15.15 Conmed Corporation

16. Appendix

  • 16.1 Abbreviations and Acronyms

  • 16.2 List of Tables

  • 16.3 List of Figures

  • 16.4 About the Publisher

  • 16.5 Research Process and Data Sources

17. Disclaimer

Enhance your decision-making capabilities with a 5 Reports-in-1
Bundle deal for - more than 40% off!

Our professional analysts will provide you with immediate assistance.